Cited by 53Global Cancer Incidence and ScreeningWomen's cancer prevention and managementColorectal Cancer Screening and Detection

Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review

Open access
Bongaerts, Thomas HG, Büchner, Frederike L, Middelkoop, Barend JC, Guicherit, Onno R, Numans, Mattijs E·2020·Journal of Medical Screening

Abstract

Objective: The Netherlands host three population-based cancer screening programmes: for cervical, breast, and colorectal cancer. For screening programmes to be effective, high participation rates are essential, but participation in the Netherlands’ programmes is starting to fall below the minimal effective rate. We aimed to produce a systematic overview of the current known determinants of (non-)attendance at the Dutch cancer screening programmes. Methods: A literature search was conducted in the electronic databases Academic Search Premier, Cochrane Library, Embase, EMCare, PubMed, PsycINFO, Web of Science, and also in grey literature, including all articles published before February 2018. The I-Change model was used to categorize the identified determinants of cancer screening attendance. Results: In total, 19/1232 identified studies and 6 grey literature reports were included. Fifteen studies reported on predisposing factors. Characteristics such as social economic status, country of birth, and residency were most often reported, and correlate with cancer screening attendance. Thirteen studies addressed information factors. Factors on awareness, motivation, ability, and barriers were less often studied. Conclusion: Current studies tend to describe the general characteristics of (non-)attendance and (non-)attenders, but rarely provide in depth information on other factors of (non-)participation. The I-Change model proved to be a useful tool in mapping current knowledge on cancer screening attendance and revealed knowledge gaps regarding determinants of (non-)participation in the screening programmes. More research is needed to fully understand determinants of participation, in order to influence and optimize attendance rates over the long term.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0969141319887996

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In systematic reviews, perceived control in personal health choices and high self-efficacy to attend screening are positively associated with screening.

    “In systematic reviews, perceived control in personal health choices and high self-efficacy to attend screening have been positively associated with screening [7,10,11,14].”

    From Improving cancer screening uptake: A behavioural and cultural insights perspective and rapid review (2026) · cites this paper as [7]

    The Results (Motivational factors; page unavailable) identify self-efficacy as an important determinant of colorectal cancer screening attendance, and Table 3 lists low self-efficacy among determinants of non-attendance. Our copy does not report an association between perceived control over personal health choices and screening. The self-efficacy finding is also specific to colorectal screening in the Dutch programmes reviewed. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Not remembering to book an appointment was one of the main reasons for non-attendance in the Netherlands.

    “Respectively, not remembering to book an appointment was one of the main reasons for non-attendance in the Netherlands (Kingdom of the) [7].”

    From Improving cancer screening uptake: A behavioural and cultural insights perspective and rapid review (2026) · cites this paper as [7]

    The Results (Ability factors; page not provided) say that forgetting to make an appointment was the main reason for non-attendance in the Dutch cervical cancer screening programme. The claim does not specify cervical screening, so it extends that finding to non-attendance more generally in the Netherlands; the passage does not establish that for the other screening programmes. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Country of birth and immigration status are associated with lower screening attendance in Denmark and the Netherlands.

    “Country of birth and immigration status have been associated with lower screening attendance in Denmark and the Netherlands (Kingdom of the) [7,18,33], likely due to language barriers and cultural beliefs [32].”

    From Improving cancer screening uptake: A behavioural and cultural insights perspective and rapid review (2026) · cites this paper as [7]

    The Results (Predisposing factors) report lower screening uptake among people not born in the Netherlands, supporting the Dutch portion of the claim. The Discussion says the review excluded international studies, so this source does not establish the Denmark portion. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In a Dutch review, non-attenders reported experiencing greater negative social influences than attenders.

    “In a Dutch review, non-attenders reported experiencing greater negative social influences than attenders.They reported negative role models (e.g., close friends or family members not attending screenings) and talked less with other people about cancer screening [7].”

    From Improving cancer screening uptake: A behavioural and cultural insights perspective and rapid review (2026) · cites this paper as [7]

    The Results (Motivational factors) state that non-attenders of the Dutch cervical cancer screening programme experienced greater negative social influences, reported negative role models, and talked less with others about screening. The citing sentence does not limit the finding to cervical screening, and the passage does not identify the role models specifically as close friends or family members. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Social supports facilitate self-efficacy, which in turn is associated with screening attendance.

    “Such supports are important because they facilitate self-efficacy, which in turn is associated with screening attendance [7,10,11,14].”

    From Improving cancer screening uptake: A behavioural and cultural insights perspective and rapid review (2026) · cites this paper as [7]

    The Results (Motivational factors; page unavailable) identify self-efficacy as a determinant of colorectal screening attendance and report that cervical-screening non-attenders experienced more negative social influences. The review does not establish the claimed link that social supports facilitate self-efficacy; its Discussion treats social influence and self-efficacy as separate influences on motivation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 48 · Cited by 53

Research works printed but not linked: 43

  1. [1]van Ballegooijen M Hermens R. Cervical cancer screening in the Netherlands. Eur J Cancer 2000; 36: 2244– 2246. 11072213
  2. [2]van Ballegooijen M van den Akker-van Marle E Patnick J, et al Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000; 36: 2177– 2188. 11072201
  3. [3]Verbeek ALM Broeders M. Evaluation of the Netherlands breast cancer screening programme. Ann Oncol 2003; 14: 1203– 1205. 12881378
  4. [4]European Colorectal Cancer Screening Guidelines Working Group, Von Karsa L Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51– 59. 23212726 PMC4482205
  5. [16]Moher D Liberati A Tetzlaff J, et al Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. 19621072 PMC2707599
  6. [19]Tong A Sainsbury P Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349– 357. 17872937
  7. [20]de Vries H Mesters I Van de Steeg H, et al The general public’s information needs and perceptions regarding hereditary cancer: an application of the integrated change model. Patient Educ Couns 2005; 56: 154– 165. 15653244
  8. [21]Groenenberg I Crone MR van Dijk S, et al ‘ Check it out!’ decision-making of vulnerable groups about participation in a two-stage cardiometabolic health check: a qualitative study. Patient Educ Couns 2015; 98: 234– 244. 25457176
  9. [22]Nierkens V Stronks K Van Oel CJ, et al Beliefs of Turkish and Moroccan immigrants in the Netherlands about smoking cessation: implications for prevention. Health Educ Res 2005; 20: 622– 634. 15781443
  10. [24]Janz NK Becker MH. The health belief model: a decade later. Health Educ Q 1984; 11: 1– 47. 6392204
  11. [25]Rogers RW. A protection motivation theory of fear appeals and attitude change1. J Psychol 1975; 91: 93– 114. 28136248
  12. [26]Weinstein ND Lyon JE Sandman PM, et al Experimental evidence for stages of health behavior change: the precaution adoption process model applied to home radon testing. Health Psychol 1998; 17: 445. 9776003
  13. [28]Vermeer B van Den Muijsenbergh METC. The attendance of migrant women at the national breast cancer screening in the Netherlands 1997–2008. Eur J Cancer Prev 2010; 19: 195– 198. 20150815
  14. [29]Kreuger FAF van Oers HAM Nijs HGT. Cervical cancer screening: spatial associations of outcome and risk factors in Rotterdam. Public Health 1999; 113: 111– 115. 10910407
  15. [30]Tacken MAJB Braspenning JCC Hermens RPMG, et al Uptake of cervical cancer screening in the Netherlands is mainly influenced by women’s beliefs about the screening and by the inviting organization. Eur J Public Health 2007; 17: 178– 185. 16837520
  16. [31]van Leeuwen AWFM de Nooijer P Hop WCJ. Screening for cervical carcinoma: participation and results for ethnic groups and socioeconomic status. Cancer 2005; 105: 270– 276. 15937918
  17. [32]Gok M Heideman DAM Van Kemenade FJ, et al Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012; 48: 1799– 1808. 22172570
  18. [33]Gok M Heideman DAM Van Kemenade FJ, et al HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: 905. PMC2837143 20223872
  19. [34]Visser O van Peppen AM Ory FG, et al Results of breast cancer screening in first generation migrants in Northwest Netherlands. Eur J Cancer Prev 2005; 14: 251– 255. 15901994
  20. [35]Aarts MJ Voogd AC Duijm LEM, et al Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands-associations with stage at diagnosis and survival. Breast Cancer Res Treat 2011; 128: 517– 525. 21290176
  21. [36]Bosgraaf RP Ketelaars PJW Verhoef VMJ, et al Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med 2014; 64: 108– 113. 24736093
  22. [37]de Nooijer DP de Waart FG van Leeuwen AWFM, et al Participation in the Dutch national screening programme for uterine cervix cancer higher after invitation by a general practitioner, especially in groups with a traditionally low level of attendance. Ned Tijdschr Geneeskd 2005; 149: 2339– 2343 (in Dutch). 16261714
  23. [38]Deutekom M Rijn A Dekker E, et al Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health 2009; 400– 402. 19372193
  24. [39]Knops-Dullens T de Vries N de Vries H. Reasons for non-attendance in cervical cancer screening programmes: an application of the integrated model for behavioural change. Eur J Cancer Prev 2007; 16: 436– 445. 17923815
  25. [40]van Rijn AF van Rossum LGM Deutekom M, et al Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. J Public Health 2008; 30: 461– 465. 18716047
  26. [41]Bais AG van Kemenade FJ Berkhof J, et al Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505– 1510. 17205514
  27. [42]Bulkmans NWJ Bulk S Ottevanger MS, et al Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate. J Clin Pathol 2006; 59: 1218– 1220. 16943223 PMC1860522
  28. [43]Woudstra AJ Dekker E Essink‐Bot ML, et al Knowledge, attitudes and beliefs regarding colorectal cancer screening among ethnic minority groups in the Netherlands – a qualitative study. Health Expect 2016; 19: 1312– 1323. 26576015 PMC5139054
  29. [44]Toes-Zoutendijk E van Leerdam ME Dekker E, et al Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels. Gastroenterology 2017; 152: 767– 775.e2. 27890769
  30. [45]Hermens RPMG Tacken MAJB Hulscher MEJL, et al Attendance to cervical cancer screening in family practices in the Netherlands. Prev Med 2000; 30: 35– 42. 10642458
  31. [46]Hummel JM Steuten LGM Groothuis-Oudshoorn CJM, et al Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy 2013; 11: 499– 507. 23979875
  32. [48]Nierkens V Stronks K de Vries H. Attitudes, social influences and self-efficacy expectations across different motivational stages among immigrant smokers: replication of the∅ pattern. Prev Med 2006; 43: 306– 311. 16919321
  33. [49]Hartman E van den Muijsenbergh ME Haneveld RW. Breast cancer screening participation among Turks and Moroccans in the Netherlands: exploring reasons for nonattendance. Eur J Cancer Prev 2009; 18: 349– 353. 19581808
  34. [50]Bosgraaf RP Siebers AG de Hullu JA, et al The current position and the future perspectives of cervical cancer screening. Expert Rev Anticancer Ther 2014; 14: 75– 92. 24308681
  35. [51]Bekker MH Lhajoui M. Health and literacy in first-and second-generation Moroccan Berber women in the Netherlands: ill literacy? Int J Equity Health 2004; 3: 8. 15222885 PMC449726
  36. [52]Navarro M Nicolas A Ferrandez A, et al Colorectal cancer population screening programs worldwide in 2016: an update. WJG 2017; 23: 3632– 3642. 28611516 PMC5449420
  37. [53]Wools A Dapper EA Leeuw JRJD. Colorectal cancer screening participation: a systematic review. Eur J Public Health 2016; 26: 158– 168. 26370437
  38. [54]Fylan F. Screening for cervical cancer: a review of women’s attitudes, knowledge, and behaviour. Br J Gen Pract 1998; 48: 1509– 1514. 10024713 PMC1313202
  39. [55]Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406– 1422. 9326910
  40. [56]Spadea T Bellini S Kunst A, et al The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med 2010; 50: 159– 164. 20093138
  41. [57]Reath J Carey M. Breast and cervical cancer in Indigenous women: overcoming barriers to early detection. Aust Fam Physician 2008; 37: 178. 18345371
  42. [58]de Klerk CM Gupta S Dekker E, et al Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut 2017; 67: 679– 687. 28073892
  43. [59]Ketelaars PJW Bosgraaf RP Siebers AG, et al High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: results of the VERA study. Prev Med 2017; 101: 96– 101. 28579497

Authors
Bongaerts, T. H., Büchner, F. L., Middelkoop, B. J., Guicherit, O. R., & Numans, M. E.
Affiliations
  • Leiden University Medical Center (NL)
  • Stichting Haaglanden Medisch Centrum (NL)
Corresponding author
Bongaerts, Thomas HG
Venue
Journal of Medical Screening
Published
2019-12-04
Volume
27
Issue
3
Pages
121-129
ISSN
  • 0969-1413 (ISSN-L)
  • 1475-5793
OpenAlex
W2993987565
Cited by
53
References
48
Citations by year
2026: 11 · 2025: 7 · 2024: 14 · 2023: 11 · 2022: 6 · 2021: 3 · 2020: 1
FWCI
0.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Screening (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Keywords
screening uptake, cervical cancer screening, breast cancer screening, colorectal cancer screening, I-Change model, determinants of participation, socioeconomic status, birthplace, barriers to screening, screening awareness
MeSH terms
Adult, Attitude to Health, Breast Neoplasms, Uterine Cervical Neoplasms, Female, Humans, Male, Middle Aged, Neoplasms, Netherlands, Patient Acceptance of Health Care, Colorectal Neoplasms, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review